Quoin Pharmaceuticals, Ltd. (QNRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
42127 Pleasant Forest Court
Ashburn, VA 20148-7349
United States of America (the)
Phone
703 980 4182
Website
Sector
Healthcare
Industry
Biotechnology
Employees
3
First IPO Date
August 01, 2016
| Name | Title | Pay | Year Born |
| Michael Myers | Co-Founder, Chief Executive Officer & Chairman | 1.18M | 1962 |
| Sally Lawlor | Chief Financial Officer | 539,697 | 1983 |
| Denise Carter | Co-Founder, Chief Operating Officer & Director | 951,000 | 1969 |
Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QRX003, is a topical lotion specifically formulated to address Netherton Syndrome. Furthermore, the company is advancing QRX004 for the management of dystrophic epidermolysis bullosa, alongside QRX006, a prospective therapy for an additional rare dermatological ailment. The organization maintains its operational base in Ashburn, Virginia.